CardioFocus logo — Lesion Creation at the Speed of Light

CardioFocus

Lesion Creation at the Speed of Light

Founded 1990 65 employees Series Unknown Total: $205.30M Biotechnology, Health Care +2

General Information

Company Name CardioFocus
Founded Year 1990
Founders / Decision Makers
Team member Team member
Employees 65
Industries Biotechnology, Health Care, Medical Devices +1
Funding Stage Series Unknown
Social

Get notified when CardioFocus moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CardioFocus

CardioFocus is a pioneering medical device company specialized in advancing ablation treatment for cardiac disorders, particularly atrial fibrillation (AFib). Its FDA-approved HeartLight Endoscopic Ablation System has effectively treated over 10,000 patients globally with its revolutionary catheter ablation technology, which offers direct visualization and titratable laser energy. The system has become a new standard for AFib ablation. Established in 1990 and headquartered in Marlborough, MA, CardioFocus operates within the industries of Biotechnology, Healthcare, Medical Devices, and Pharmaceuticals. The company's recent Debt Financing investment on February 23, 2023 underscores investor confidence in its innovative approach to improving cardiac care. While the specific investors involved in this round are not disclosed, the investment signifies ongoing support and belief in CardioFocus' mission. With its impactful slogan "Lesion Creation at the Speed of Light," CardioFocus continues to drive advancements in cardiac health and stands as a notable player in the medical technology landscape. For more details, interested parties can visit www.CardioFocus.com.

Taxonomy: Ablation Treatment, Cardiac Disorders, Atrial Fibrillation, Electrophysiology, Innovative Technology, Catheter Ablation, Fiber Optic Catheters, Cardiac Arrhythmias, FDA-approved, Healthcare Innovation, Clinical Treatment, Medical Innovations, Cardiology

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 23 Feb 2023
Debt Financing •••••• - 23 Feb 2023
Venture Round •••••• - 12 Apr 2022
Venture Round •••••• - 07 Jul 2020
Venture Round •••••• 1 •••• •••• 29 May 2019

View All 15 Funding Rounds

CardioFocus Alternatives & Competitors

CardioFocus vs
EBAMed
EBAMed Switzerland

Ultrasound Guidance during Radio Ablation Treatment of Cardiac Arrhythmias

Series A
16 employees
Health Care
CardioFocus vs

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF techno...

Series C
Biopharma, Biotechnology
CardioFocus vs
S4 Medical
S4 Medical United States

S4 Medical is a medical device company addressing a complication associated with treatment of atrial...

Series B
14 employees
Health Care, Medical Devices

FAQ About CardioFocus

Lesion Creation at the Speed of Light
CardioFocus was founded in 1990.
CardioFocus operates in the following industries: Biotechnology, Health Care, Medical Devices, Pharmaceutical.
CardioFocus has approximately 65 employees.
CardioFocus has completed 15 funding rounds, raising a total of $205.30M. The latest funding stage is Series Unknown.
Top alternatives and competitors to CardioFocus include EBAMed, Ablation Frontiers, S4 Medical, ElectroPhysiology Frontiers S.p.A., Argá Medtech SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioFocus and EBAMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CardioFocus and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy